SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales surged to Rs. 4252.40 millions, up 25.67% for the September 2023 quarter as against Rs. 3383.70 millions during the corresponding quarter previous year.The Net Loss for the quarter ended September 2023 is Rs. -152.60 millions as compared to Net Loss of Rs. -99.10 millions of corresponding quarter ended September 2022Operating profit surged to 389.00 millions from the corresponding previous quarter of 312.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4252.40 3383.70 25.67 7775.50 6684.40 16.32 14438.10 12683.40 13.83
Other Income 12.30 37.70 -67.37 33.00 102.50 -67.80 221.40 187.60 18.02
PBIDT 389.00 312.90 24.32 601.10 474.50 26.68 1561.80 991.10 57.58
Interest 244.70 219.60 11.43 499.80 444.60 12.42 900.60 752.70 19.65
PBDT 108.80 93.30 16.61 65.80 29.90 120.07 661.20 203.50 224.91
Depreciation 261.40 285.60 -8.47 519.70 566.10 -8.20 1109.00 1120.10 -0.99
PBT -152.60 -192.30 -20.64 -453.90 -536.20 -15.35 -447.80 -916.60 -51.15
TAX 0.00 -93.20 0.00 -102.50 -245.30 -58.21 -225.70 -331.00 -31.81
Deferred Tax 0.00 -93.20 0.00 -102.50 -245.30 -58.21 -224.60 -331.00 -32.15
PAT -152.60 -99.10 53.99 -351.40 -290.90 20.80 -222.10 -585.60 -62.07
Equity 360.00 360.00 0.00 360.00 360.00 0.00 360.00 360.00 0.00
PBIDTM(%) 9.15 9.25 -1.08 7.73 7.10 8.90 10.82 7.81 38.43

Solara Active Pharma Share Price

488.80 -4.90 (-0.99%)
16-Apr-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 938.00
Lupin 2322.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×